Merck & Co., Inc. vs Pfizer Inc.: Stock Comparison
Share price, earnings, valuation and dividends side by side.
Merck & Co., Inc. has a market cap of $362B and Pfizer Inc. $168B, so Merck & Co., Inc. is about 2.2 times the size of Pfizer Inc..
Operating margin is 16.7% for Merck & Co., Inc. and 25.1% for Pfizer Inc..
The P/E ratio (TTM) is 116.4x for Merck & Co., Inc. and 38.8x for Pfizer Inc..
Dividend yield is 2.32% for Merck & Co., Inc. and 5.85% for Pfizer Inc..
In each row, the better figure is highlighted based only on the number itself. This does not say which is the better investment.
| MRKMerck & Co., Inc.Healthcare | PFEPfizer Inc.Healthcare | |
|---|---|---|
| Basics | ||
| Market cap | $362B | $168B |
| Share price | $146.71 | $29.39 |
| 1-year return | +76.0% | +26.6% |
| 5-year return | +109.4% | −21.9% |
| Valuation | ||
| P/E (TTM) | 116.4x | 38.8x |
| Forward P/E | 55.2x | 9.9x |
| P/S | 5.5x | 2.6x |
| P/B | 8.6x | 2.0x |
| EV/EBITDA | 29.4x | 17.0x |
| Profitability | ||
| Revenue (TTM) | $66.4B | $63.7B |
| Gross margin | 75.4% | 71.3% |
| Operating margin | 16.7% | 25.1% |
| Net margin | 4.8% | 6.8% |
| ROE | 6.6% | 4.9% |
| Growth | ||
| Revenue growth (YoY) | +4.2% | — |
| Revenue CAGR (5Y) | +9.4% | +8.5% |
| EPS CAGR (5Y) | +21.2% | −3.5% |
| Dividends & balance sheet | ||
| Dividend yield | 2.32% | 5.85% |
| Years of dividend growth | — | — |
| FCF yield | 4.4% | 6.6% |
| Debt/equity (lower = less debt) | 1.29x | 0.74x |
Other comparisons
Listed mechanically from public data. Not a recommendation to buy or sell any security.